Source OpenAI · Published · Open the original ↗
Lab notes
OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
OpenAI publishes this post on its own site. Supence shows only what the publisher allows to be quoted.